At the time of writing, Co-Diagnostics Inc [CODX] stock is trading at $1.00, up 28.21%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CODX shares have gain 36.99% over the last week, with a monthly amount glided 14.16%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Co-Diagnostics Inc [NASDAQ: CODX] stock has seen the most recent analyst activity on August 12, 2022, when Sidoti downgraded its rating to a Neutral but kept the price target unchanged to $5 for it. Previously, Sidoti started tracking the stock with Buy rating on December 29, 2021, and set its price target to $14. On March 29, 2021, downgrade downgraded it’s rating to Hold. Maxim Group upgraded its rating to a Buy. H.C. Wainwright reiterated its recommendation of a Buy and raised its price target to $35 on May 18, 2020. H.C. Wainwright reiterated a Buy rating for this stock on March 09, 2020, and upped its price target to $20. In a note dated March 03, 2020, Maxim Group downgraded an Hold rating on this stock.
For the past year, the stock price of Co-Diagnostics Inc fluctuated between $0.67 and $2.23. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Co-Diagnostics Inc [NASDAQ: CODX] shares were valued at $1.00 at the most recent close of the market. An investor can expect a potential return of 500.0% based on the average CODX price forecast.
Analyzing the CODX fundamentals
According to Co-Diagnostics Inc [NASDAQ:CODX], the company’s sales were 4.18M for trailing twelve months, which represents an -91.58% plunge. Gross Profit Margin for this corporation currently stands at -0.02% with Operating Profit Margin at -9.26%, Pretax Profit Margin comes in at -8.11%, and Net Profit Margin reading is -8.96%. To continue investigating profitability, this company’s Return on Assets is posted at -0.57, Equity is -0.55 and Total Capital is -0.64.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8327 points at the first support level, and at 0.6655 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1186, and for the 2nd resistance point, it is at 1.2373.
Ratios To Look Out For
It is important to note that Co-Diagnostics Inc [NASDAQ:CODX] has a current ratio of 6.92. In addition, the Quick Ratio stands at 6.70 and the Cash Ratio stands at 1.86. Considering the valuation of this stock, the price to sales ratio is 8.25, the price to book ratio is 0.50.
